IP Landscape- Lipid Nanoparticles for Biomolecules Delivery
A global pharmaceutical leader partnered with Stellarix to gain strategic insights into lipid nanoparticle (LNP) systems for biomolecule delivery. With LNPs emerging as a critical platform for mRNA, siRNA, and CRISPR-based therapeutics, recognized and regulated by the FDA—our case study mapped key components, formulation strategies, and advanced manufacturing practices. Client Background: The client is a […]
Bispecific Antibody-Drug Conjugates: Clinical Development and Future Directions
In the last decade, ADCs have been an emerging class of medical modalities to treat cancer by combining potent anti-cancer medicines (i.e., payloads) with monoclonal antibodies that deliver cancer medicines to the target cells. According to the market reports, the global ADC request size was valued at around 11.84 billion USD in 2024 and is […]
Threat and Opportunity Assessment for Pharmaceutical Products
A pharmaceutical product is any drug product that is approved by the FDA or other county-specific regulators for the treatment of specific diseases after comprehensive research and clinical development to ensure its efficacy and safety in patients when administered at the recommended dose. Sales growth of marketed pharmaceutical products depends on multiple parameters, such as […]
Rx to OTC Switch: Overview, Regulatory Requirement and Potential Switch Candidates
Rx-to-OTC switch is the transfer of prescription-based drugs to non-prescription or over-the-counter status. It is a highly regulated and rigorous process that allows consumers to have OTC access to certain medicines with a high safety margin and is effective in treating self-diagnosable conditions. Over-the-counter products are broadly classified into key categories based on their therapeutic […]
Next-Generation Radiopharmaceuticals
The medical industry is in the midst of a revolution using next-generation radiopharmaceuticals and making use of advanced technology and innovative targeting strategies. These modern agents are better than traditional ones because they can infiltrate cells and tissues that were previously regarded as quite difficult to penetrate through mechanisms such as endocytosis and receptor-mediated uptake. […]
Foam-Based Drug Delivery: Emerging Pharmaceuticals Dosage
The use of foam-based delivery systems in the field of drug delivery is an innovative approach in the sector of pharmaceutical science that has brought a new dispensation of drugs through creative formulations. Foam-based systems do not use typical dosage forms; instead, they change liquid drugs into stable foams as soon as they are activated […]
Comparator Drugs: A Critical Element in Clinical Research
Comparator drugs are of significant importance in clinical research. Based on pharmaceutical comparator studies and blind comparator stability testing, a drug product’s similarity or superiority to a commercial drug product in the same therapeutic class can be determined.With rising diseases, pharmaceutical companies are under pressure to develop strong strategies for choosing a comparator drug and […]
Partner Scouting: Integrated Solutions for Hypertension Management
A renowned company dealing in healthcare technology engaged with Stellarix for partner scouting, identifying potential vendors for software and hardware solutions. The client sought technology that could help patients suffering from cardiovascular issues. It requested planning to select CROs (Contract Research Organizations) and sponsors to extend their clinical research. The findings helped the client make […]
Landscape: Child Resistant Packaging
A startup engaged with Stellarix to learn more about the child-resistant (CR) packaging market, technological advancement, size, trends, and regulations of the landscape. It requested that the CR packaging segment be explored, as well as emerging innovations and major players participating in the sector. The study provided the client with important insights that helped the […]
Technology Scouting: Emerging Technologies for Drug Traceability
A top pharmaceutical company contacted Stellarix to learn more about technological advancements like smart sensors and artificial intelligence in the industry to enhance drug traceability. The client wanted to delve into regulatory compliance, reliability, and pharma tracking and grasp an edge over competitors with accuracy and operational efficiencies, offering cost-effectiveness, safety, and leadership. Client Background […]